Lifeward (NASDAQ:LFWD) Stock Price Down 6.4% – Here’s Why

Lifeward Ltd. (NASDAQ:LFWD)’s share price fell 6.4% during trading on Tuesday. The company traded as low as $5.61 and last traded at $5.55. Approximately 1,820 shares changed hands during trading, a decline of 70% from the average daily volume of 6,156 shares. The stock had previously closed at $5.93.

Analyst Upgrades and Downgrades

Several analysts have issued reports on LFWD shares. HC Wainwright restated a “buy” rating and issued a $10.00 target price on shares of Lifeward in a report on Friday, August 21st. Weiss Ratings raised Lifeward from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, October 9th. Citigroup reiterated a “buy” rating on shares of Lifeward in a report on Friday, August 21st. Finally, Zacks Research raised shares of Lifeward from a “strong sell” rating to a “hold” rating in a research report on Monday, July 27th. Two research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Lifeward has a consensus rating of “Hold” and a consensus target price of $10.00.

Lifeward Stock Performance

The business has a fifty day moving average of $6.85 and a 200 day moving average of $7.09. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.33 and a quick ratio of 1.77.

Lifeward (NASDAQ:LFWD) last issued its quarterly earnings data on Saturday, August 15th. The company reported ($1.46) earnings per share for the quarter, missing the consensus estimate of ($1.39) by ($0.07). The business had revenue of $6.62 million during the quarter, compared to analysts’ expectations of $6.53 million. Lifeward had a negative return on equity of 235.86% and a negative net margin of 141.28%. As a group, analysts anticipate that Lifeward Ltd. will post -0.44 EPS for the current year.

Lifeward Company Profile

Lifeward Ltd., formerly known as ReWalk Robotics Ltd., is a medical technology company focused on developing wearable robotic systems that support mobility and rehabilitation. Its technologies are designed primarily for people with lower-limb disabilities, including individuals with spinal cord injury, as well as patients recovering from neurological conditions such as stroke.

The company’s principal products include the ReWalk Personal Exoskeleton, a wearable robotic device intended to help eligible individuals stand, walk and perform daily activities, and the ReStore Exo-Suit, a soft, lightweight robotic system designed for use in rehabilitation centers to assist gait training.